• Company
  • News
  • Investors
  • Contacts
  • Careers
PPTPPTlogo-mobilePPT
  • Services
    • GMP Compliance
    • Pre-GMP development
    • Production
    • Quality Assurance
    • Quality control
    • Regulatory Support
  • Generic peptides
  • Commercial Manufacturing
    • Commercial products at PolyPeptide
    • Late stage development
    • Process development and optimization
    • Capacity and Capabilities
  • Custom R&D
    • Custom Research Grade Peptides
    • Radiolabeled peptide
  • Cosmetic
  • Individualized Peptides
  • Oligos
  • Services
    • GMP Compliance
    • Pre-GMP development
    • Production
    • Quality Assurance
    • Quality control
    • Regulatory Support
  • Generic peptides
  • Commercial Manufacturing
    • Commercial products at PolyPeptide
    • Late stage development
    • Process development and optimization
    • Capacity and Capabilities
  • Custom R&D
    • Custom Research Grade Peptides
    • Radiolabeled peptide
  • Cosmetic
  • Individualized Peptides
  • Oligos
  • Home
  • News
  • Business news
  • PolyPeptide wins Malmö Life Science Business Award

PolyPeptide wins Malmö Life Science Business Award

28 June 2022
Business news

Malmö, 21 June 2022

We are proud of our site in Malmö, Sweden, for winning the Life Science Business Award of the city (Malmö Näringslivspris Life Science). The jury stressed the important role of PolyPeptide as part of Malmö’s Life Science cluster, recognizing the continued growth and positive developments as a high-quality, responsible employer.

Jens Fricke, the site director of PolyPeptide in Malmö, commented: “I would like to thank all the employees: The award reflects their efforts, engagement, and our great team spirit. We ultimately work to the benefit of millions of patients and see the award as an additional motivation to keep up the good work!”.

As per the end of 2021, PolyPeptide had 293 people employed in Malmö, with hiring ongoing to keep up with business growth. The company has its heritage in the city, where the manufacturing of Peptides started in 1952. Over the last 70 years, PolyPeptide developed into a contract development and manufacturing organization with over 1’100 employees globally, supporting customers worldwide with the development and manufacturing of innovative peptide- and oligonucleotides-based drugs.

Download PDF

Back to news

Related posts

9 November 2022

FluoGuide reaches milestone with FG001 for phase III clinical supply


Read more
22 December 2021

Efficient and sustainable solutions for large scale peptide manufacturing


Read more
11 May 2021

Proclamation honoring Jane Salik upon her retirement


Read more

Polypeptide Group

INFO

COMPANY
LEADERSHIP
CONTACTS
CAREERS

NEWS

LATEST NEWS
SIGN UP FOR NEWS
EVENTS

SOCIALS

LINKEDIN
YOUTUBE
© Confidentiality 2021 PolyPeptide Group • Cookie management • Personal data • Sitemap • Confidentiality policy
      By clicking “Accept”, you consent to the use of ALL the cookies on our website . However you may visit Cookie Settings to provide a controlled consent.
      Cookie settingsACCEPT
      Privacy & Cookies Policy

      Privacy Overview

      You can enable or disable your consent for each category of cookie.

      More information on the collection of personal data
      Necessary
      Always Enabled

      The necessary cookies help to make a website usable by enabling basic functions such as page navigation and access to secure areas of the website. The website cannot function properly without these cookies.

      Advertisement

      Marketing cookies are used to track visitors through websites. The goal is to display ads that are relevant and interesting to the individual user and therefore more valuable to third-party publishers and advertisers.

      Analytics

      Statistical cookies help website owners, through the anonymous collection and communication of information, to understand how visitors interact with websites.

      Performance

      Preferences cookies allow a website to retain information that changes the way the site behaves or displays, such as your preferred language or the region in which you are located.

      Save & Accept